News and Announcements
Moggill Village | Financial Close April 2020
- Published April 29, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Newground Capital Partners is proud to announce financial close of a $12m structured finance facility for a Coles anchored neighbourhood centre in metro Brisbane.
This transaction demonstrates Newground’s willingness and ability to provide bespoke funding solutions to its project partners during exceptionally challenging times.
“We are very pleased to be partnering with Consolidated Properties Group to deliver what has proven to be ‘essential’ real estate during the recent COVID-19 crisis. Assets such as these provide much needed amenity to the local community and we believe will remain in high demand amongst investors seeking defensive income.”
– Daniel Erez, Managing Director
About Newground Capital
Newground Capital Partners are real estate debt & equity partners. The company invests across all sectors of real estate development alongside proven sponsors who require additional capital to grow and execute their project pipeline. Newground provides investors with access to off-market proprietary deal flow, genuine alignment of interest via co-investment, combined with years of experience and a proven track record.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
